Business Segments · Net Sales
Neuroscience — Net Sales
Medtronic Neuroscience — Net Sales decreased by 0.2% to $2.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.1%, from $2.46B to $2.56B. Over 4 years (FY 2021 to FY 2025), Neuroscience — Net Sales shows an upward trend with a 3.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2019
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
Growth indicates successful product adoption and market share expansion, whereas a decline may signal market saturation or competitive loss.
Detailed definition
This represents the total revenue generated from the sale of neuroscience-related medical devices, net of returns, allow...
Peer comparison
Directly comparable to revenue figures for specific business units in other medical technology companies.
Metric ID:
mdt_segment_neuroscience_net_salesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.21B | $2.20B | $2.14B | $2.14B | $2.16B | $2.12B | $2.19B | $2.25B | $2.26B | $2.22B | $2.29B | $2.36B | $2.41B | $2.32B | $2.45B | $2.46B | $2.52B | $2.42B | $2.56B | $2.56B |
| QoQ Change | — | -0.5% | -3.1% | +0.4% | +0.6% | -1.9% | +3.4% | +2.8% | +0.4% | -1.7% | +3.1% | +2.9% | +2.5% | -4.0% | +5.8% | +0.3% | +2.5% | -4.1% | +6.0% | -0.2% |
| YoY Change | — | — | — | — | -2.6% | -4.0% | +2.3% | +4.9% | +4.7% | +4.9% | +4.7% | +4.8% | +6.9% | +4.4% | +7.1% | +4.4% | +4.4% | +4.3% | +4.5% | +4.1% |
Range$2.12B – $2.56B
CAGR+3.1%
Avg YoY Growth+3.7%
Median YoY Growth+4.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's neuroscience — net sales?
- Medtronic (MDT) reported neuroscience — net sales of $2.56B in Q1 2026.
- How has Medtronic's neuroscience — net sales changed year-over-year?
- Medtronic's neuroscience — net sales increased by 4.1% year-over-year, from $2.46B to $2.56B.
- What is the long-term trend for Medtronic's neuroscience — net sales?
- Over 4 years (2021 to 2025), Medtronic's neuroscience — net sales has grown at a 3.5% compound annual growth rate (CAGR), from $8.68B to $9.96B.
- What does neuroscience — net sales mean?
- Total revenue earned from selling neuroscience medical products.